Index S&P 500
P/E 39.17
EPS (ttm) 8.97
Insider Own 6.16%
Shs Outstand 380.10M
Perf Week -2.51%
Market Cap 133.84B
Forward P/E 26.04
EPS next Y 13.49
Insider Trans -0.98%
Shs Float 357.61M
Perf Month -1.89%
Income 3.45B
PEG 3.82
EPS next Q 2.77
Inst Own 79.47%
Short Float 1.19%
Perf Quarter 5.12%
Sales 21.39B
P/S 6.26
EPS this Y 13.25%
Inst Trans 0.88%
Short Ratio 3.51
Perf Half Y 0.06%
Book/sh 51.86
P/B 6.77
EPS next Y 12.36%
ROA 9.01%
Short Interest 4.27M
Perf Year 31.94%
Cash/sh 5.14
P/C 68.39
EPS next 5Y 10.25%
ROE 18.58%
52W Range 249.98 - 374.63
Perf YTD 17.28%
Dividend Est. 3.15 (0.90%)
P/FCF 47.75
EPS past 5Y -2.45%
ROI 11.39%
52W High -6.25%
Beta 0.92
Dividend TTM 3.20 (0.91%)
Quick Ratio 0.95
Sales past 5Y 8.80%
Gross Margin 61.21%
52W Low 40.50%
ATR (14) 5.72
Dividend Ex-Date Sep 30, 2024
Current Ratio 1.68
EPS Y/Y TTM 26.82%
Oper. Margin 21.38%
RSI (14) 40.54
Volatility 1.60% 1.55%
Employees 52000
Debt/Eq 0.64
Sales Y/Y TTM 9.94%
Profit Margin 16.12%
Recom 1.82
Target Price 381.00
Option/Short Yes / Yes
LT Debt/Eq 0.53
EPS Q/Q 11.35%
Payout 36.98%
Rel Volume 0.55
Prev Close 351.61
Sales Surprise 0.32%
EPS Surprise 0.66%
Sales Q/Q 8.53%
Earnings Oct 29 AMC
Avg Volume 1.22M
Price 351.22
SMA20 -3.14%
SMA50 0.71%
SMA200 3.79%
Trades
Volume 669,455
Change -0.11%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-10-24 Initiated
Wolfe Research
Outperform
$405
May-30-24 Initiated
Goldman
Neutral
$372
May-22-24 Upgrade
Needham
Hold → Buy
$392
Jan-31-24 Upgrade
Canaccord Genuity
Hold → Buy
$315 → $360
Oct-20-23 Initiated
ROTH MKM
Buy
$345
Sep-05-23 Upgrade
BofA Securities
Neutral → Buy
$310 → $315
Mar-29-23 Initiated
UBS
Neutral
$287
Jan-25-23 Initiated
KeyBanc Capital Markets
Sector Weight
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$240 → $284
Nov-01-22 Downgrade
Canaccord Genuity
Buy → Hold
$225 → $220
Oct-18-22 Initiated
Barclays
Overweight
$239
Oct-12-22 Initiated
Jefferies
Buy
$270
Jul-28-22 Upgrade
Edward Jones
Hold → Buy
Jul-21-22 Downgrade
Deutsche Bank
Buy → Hold
$285 → $205
Jul-11-22 Downgrade
BofA Securities
Buy → Neutral
$215
Apr-13-22 Initiated
Truist
Hold
$296
Mar-16-22 Upgrade
Bernstein
Mkt Perform → Outperform
$288 → $295
Mar-15-22 Resumed
Evercore ISI
Outperform
$284
Mar-02-22 Resumed
BofA Securities
Buy
$300
Jan-07-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$305
Show Previous Ratings
Oct-01-24 04:00PM
10:21AM
(Design & Development Today)
08:00AM
Sep-23-24 07:17AM
Sep-20-24 10:13AM
08:00AM
Loading…
08:00AM
Sep-17-24 11:34AM
Sep-12-24 10:00AM
06:32AM
Sep-11-24 08:05AM
Aug-30-24 07:04PM
Aug-29-24 11:31AM
Aug-28-24 06:55PM
Aug-23-24 01:33PM
(Design & Development Today)
10:57AM
06:24AM
Loading…
06:24AM
Aug-22-24 10:33AM
08:00AM
Aug-21-24 01:19PM
Aug-19-24 04:00PM
Aug-14-24 09:50AM
Aug-13-24 11:26AM
05:52AM
Aug-12-24 08:00AM
07:45AM
Aug-08-24 12:11PM
Aug-07-24 08:00AM
Aug-06-24 01:04PM
08:05AM
Aug-02-24 12:59PM
01:08AM
Loading…
Aug-01-24 01:08AM
Jul-31-24 04:12PM
(Investor's Business Daily)
03:00PM
12:08PM
11:13AM
10:31AM
09:40AM
08:45AM
06:33AM
Jul-30-24 08:57PM
05:15PM
04:18PM
(Investor's Business Daily)
04:14PM
(Associated Press Finance)
04:05PM
08:47AM
Jul-29-24 08:55AM
Jul-26-24 09:15AM
Jul-17-24 04:05PM
Jul-16-24 12:16PM
Jul-15-24 12:13PM
08:00AM
Jul-12-24 02:14AM
Jul-09-24 10:07AM
Jul-01-24 04:00PM
Jun-27-24 09:44AM
Jun-21-24 05:07AM
Jun-19-24 01:53PM
Jun-18-24 09:07AM
Jun-17-24 03:15PM
Jun-05-24 12:08PM
06:46AM
Jun-04-24 12:39PM
09:05AM
04:45AM
01:38AM
Jun-03-24 08:00AM
May-31-24 12:01AM
May-30-24 11:51AM
May-29-24 03:27PM
(Investor's Business Daily)
02:30PM
01:01PM
02:10AM
May-28-24 02:15PM
May-23-24 06:30AM
May-22-24 09:36AM
May-16-24 04:21PM
May-09-24 08:00AM
07:58AM
May-07-24 02:10AM
May-02-24 01:02AM
May-01-24 04:12PM
(Investor's Business Daily)
11:53AM
11:32AM
09:55AM
09:55AM
09:54AM
09:54AM
09:51AM
09:44AM
09:39AM
09:36AM
09:13AM
08:27AM
08:26AM
07:55AM
07:25AM
(Thomson Reuters StreetEvents)
06:08AM
03:27AM
Apr-30-24 08:57PM
06:11PM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Fink M Kathryn VP, Chief HR Officer Sep 16 '24 Option Exercise 122.51 7,347 900,081 17,389 Sep 17 06:01 PM Fink M Kathryn VP, Chief HR Officer Sep 17 '24 Sale 366.98 7,347 2,696,186 10,042 Sep 17 06:01 PM Fink M Kathryn VP, Chief HR Officer Sep 13 '24 Sale 370.00 2,121 784,770 10,042 Sep 17 06:01 PM Fink M Kathryn Officer Sep 17 '24 Proposed Sale 371.19 7,347 2,727,133 Sep 17 04:07 PM Fink M Kathryn Officer Sep 13 '24 Proposed Sale 370.00 2,121 784,770 Sep 13 04:06 PM Menon Viju Group President Aug 27 '24 Sale 355.00 600 213,000 9,069 Aug 27 05:22 PM Viju Menon Officer Aug 27 '24 Proposed Sale 355.00 600 213,000 Aug 27 04:04 PM STRYKER RONDA E Director Aug 06 '24 Sale 323.46 190,000 61,457,149 3,316,608 Aug 08 04:23 PM STRYKER RONDA E Director Aug 06 '24 Proposed Sale 322.45 190,000 61,265,500 Aug 06 10:57 AM Boehnlein Glenn S VP, Chief Financial Officer Aug 02 '24 Sale 333.00 20,000 6,660,000 2,852 Aug 02 04:17 PM Glenn Boehnlein Officer Aug 02 '24 Proposed Sale 333.00 20,000 6,659,994 Aug 02 11:43 AM Boehnlein Glenn S VP, Chief Financial Officer Jul 02 '24 Option Exercise 122.51 25,000 3,062,750 40,012 Jul 03 04:33 PM Fletcher Robert S VP, Chief Legal Officer May 22 '24 Sale 332.99 2,007 668,308 8,896 May 23 04:06 PM Boehnlein Glenn S VP, Chief Financial Officer May 15 '24 Sale 327.65 10,000 3,276,516 15,012 May 16 04:16 PM Stiles Spencer S Group President Mar 21 '24 Option Exercise 0.00 203 0 55,602 Mar 25 07:21 PM Pierce James Andrew Group President Mar 21 '24 Option Exercise 0.00 203 0 60,664 Mar 25 07:16 PM Menon Viju Group President Mar 21 '24 Option Exercise 0.00 158 0 13,762 Mar 25 07:11 PM Lobo Kevin Chair and CEO Mar 21 '24 Option Exercise 0.00 905 0 119,719 Mar 25 06:58 PM Fletcher Robert S VP, Chief Legal Officer Mar 21 '24 Option Exercise 0.00 120 0 13,143 Mar 25 06:54 PM Fink M Kathryn VP, Chief HR Officer Mar 21 '24 Option Exercise 0.00 83 0 13,710 Mar 25 06:50 PM Boehnlein Glenn S VP, Chief Financial Officer Mar 21 '24 Option Exercise 0.00 256 0 31,152 Mar 25 06:45 PM Becker Yin C VP, Chief Corp Affairs Officer Mar 21 '24 Option Exercise 0.00 36 0 29,898 Mar 25 06:37 PM Berry William E Jr VP, Chief Accounting Officer Mar 07 '24 Option Exercise 108.30 17,660 1,912,588 21,335 Mar 11 05:55 PM Berry William E Jr VP, Chief Accounting Officer Mar 08 '24 Option Exercise 154.14 1,480 228,127 5,155 Mar 11 05:55 PM Berry William E Jr VP, Chief Accounting Officer Mar 07 '24 Sale 358.48 7,690 2,756,730 3,675 Mar 11 05:55 PM Boehnlein Glenn S VP, Chief Financial Officer Feb 09 '24 Sale 342.81 9,600 3,290,952 20,194 Feb 12 04:09 PM STRYKER RONDA E Director Feb 05 '24 Sale 342.90 201,146 68,973,360 3,755,128 Feb 07 05:33 PM STRYKER RONDA E Director Feb 06 '24 Sale 339.95 92,296 31,376,021 3,662,832 Feb 07 05:33 PM Becker Yin C VP, Chief Corp Affairs Officer Feb 05 '24 Option Exercise 93.06 8,060 750,064 33,129 Feb 07 05:00 PM Golston Allan C. Director Feb 02 '24 Option Exercise 96.64 4,570 441,645 18,812 Feb 06 05:24 PM Golston Allan C. Director Feb 02 '24 Sale 341.00 3,273 1,116,093 14,242 Feb 06 05:24 PM STRYKER RONDA E Director Feb 02 '24 Option Exercise 81.14 4,355 353,365 7,642 Feb 06 05:16 PM Pierce James Andrew Group President Jan 16 '24 Option Exercise 81.14 10,230 830,062 57,999 Jan 16 04:23 PM Boehnlein Glenn S VP, Chief Financial Officer Jan 11 '24 Option Exercise 95.99 60,005 5,760,022 68,981 Jan 16 04:16 PM Silvernail Andrew K Director Dec 05 '23 Option Exercise 81.14 4,355 353,365 11,472 Dec 07 04:57 PM Datar Srikant M. Director Dec 04 '23 Option Exercise 93.06 1,795 167,043 5,611 Dec 05 04:25 PM Datar Srikant M. Director Dec 01 '23 Sale 298.22 500 149,112 3,816 Dec 05 04:25 PM Becker Yin C VP, Chief Corp Affairs Officer Nov 28 '23 Option Exercise 81.14 8,875 720,118 30,806 Nov 28 08:16 PM Berry William E Jr VP, Chief Accounting Officer Nov 28 '23 Sale 292.28 573 167,477 2,909 Nov 28 08:09 PM Boehnlein Glenn S VP, Chief Financial Officer Nov 27 '23 Option Exercise 81.14 11,955 970,029 16,570 Nov 28 08:02 PM Lobo Kevin Chair and CEO Nov 17 '23 Option Exercise 81.14 160,215 12,999,845 241,249 Nov 21 05:18 PM Lobo Kevin Chair and CEO Nov 17 '23 Sale 287.91 56,483 16,261,812 81,034 Nov 21 05:18 PM Stiles Spencer S Group President Nov 17 '23 Option Exercise 81.14 11,090 899,843 53,732 Nov 21 04:33 PM Datar Srikant M. Director Nov 14 '23 Sale 287.57 750 215,681 5,316 Nov 16 05:56 PM Datar Srikant M. Director Nov 16 '23 Sale 291.92 500 145,962 4,316 Nov 16 05:56 PM Datar Srikant M. Director Nov 15 '23 Sale 287.50 500 143,751 4,816 Nov 16 05:56 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite